A Study of ZW25 With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
Condition: HER2+/HR+ Breast Cancer Interventions: Drug: ZW25; Drug: Palbociclib; Drug: Fulvestrant Sponsor: Zymeworks Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials